Seegene Inc., a global leader in molecular diagnostics, unveiled two new technologies at ADLM 2025 in Chicago (July 29–31) ...

The South Korean firm said that its CURECA system offers walkaway PCR testing with 24/7 operation without human intervention ...

NeoGenomics launched the NEO PanTracer™ LBx, a blood-based comprehensive genomic profiling test, expanding the company’s ...

Overview of Cell Isolation MarketThe global Cell Isolation Market is valued at USD 15.6 Billion in 2024 and is projected to reach a value of USD 60.56 Billion by 2035 at a CAGR (Compound Annual Growth ...

The length of hospital stays and death among patients with chronic obstructive pulmonary disease are tied to various ...

Women with PCOS and thrombotic disease face a higher risk of vascular events like stroke and heart attack at younger ages, ...

Illumina Inc. (NASDAQ: ILMN) today announced the launch of the next generation of TruSight Oncology 500, its flagship cancer research assay that enables comprehensive genomic profiling. Comprehensive ...

In this video interview, Michael Miller, chief operating officer at Quanterix, outlines key technical and regulatory ...

The single-tier test uses artificial intelligence to accurately detect Lyme disease from the first few weeks of infection ...

Upgrades to software on Bionano’s Stratys™ Compute, a server that leverages advanced GPU chips, double the number of cancer samples that can be analyzed per week and expand functionality to include ...

It will also have the capability to provide information on the response to certain treatments The test will be easy to use, ...

Melbourne-headquartered Trajan’s capital equipment segment is at the forefront of laboratory automation and analytical ...